YaoGeJu

Company directoryChina company filings

Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.

As of 18 November 2026, for the company name Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 17 active records with this name as holder; 4 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

26 acceptance records as first applicant, grouped into 15 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Latamoxef Sodium for Injection 3 records · Latest accepted 2026/10/22

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601940Supplement2026/10/22Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.; Zhejiang Hui Di Sen Pharma Co., Ltd. romanizedCDE ↗
CYHB2601939Supplement2026/10/22Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.; Haerbin Yu Heng Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2601938Supplement2026/10/22Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.; Haerbin Yu Heng Pharmaceutical Co., Ltd. romanizedCDE ↗
磷苯妥英钠注射用浓溶液 · No verified English name 2 records · Latest accepted 2026/03/07

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600629Generic2026/03/07Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
CYHS2600628Generic2026/03/07Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Thioctic Acid Injection 2 records · Latest accepted 2025/06/28

Supplement · 1Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501281Supplement2025/06/28Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
CYHS2102123Generic2021/12/07Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Polymyxin B sulfate for Injection 1 records · Latest accepted 2025/04/01

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501237Generic2025/04/01Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Clindamycin Injection 6 records · Latest accepted 2024/11/07

Supplement · 6

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401836Supplement2024/11/07Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
CYHB2401835Supplement2024/11/07Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
CYHB2401046Supplement2024/07/16Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
CYHB2401044Supplement2024/07/16Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
CYHB2302641Supplement2023/12/01Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
CYHB2302640Supplement2023/12/01Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Ademetionine 1,4 - Butanedisulfonate For Injection 1 records · Latest accepted 2024/01/09

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400108Generic2024/01/09Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Teicoplanin for Injection 1 records · Latest accepted 2023/12/08

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2303391Generic2023/12/08Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Thioctic Acid Tablets 2 records · Latest accepted 2023/11/30

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2303304Generic2023/11/30Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
CYHS2303302Generic2023/11/30Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Famotidine Injection 1 records · Latest accepted 2023/03/07

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300718Generic2023/03/07Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Pentoxifylline Injection 1 records · Latest accepted 2022/11/01

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201865Generic2022/11/01Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Peramivir Injection 1 records · Latest accepted 2022/10/14

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201738Generic2022/10/14Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Voriconazole for Injection 1 records · Latest accepted 2022/08/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201297Generic2022/08/15Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Ornidazole Tablets 1 records · Latest accepted 2022/07/19

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201100Generic2022/07/19Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Piracetam Tablets 1 records · Latest accepted 2022/06/14

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250347Supplement2022/06/14Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Febuxostat Tablets 2 records · Latest accepted 2021/07/05

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101392Generic2021/07/05Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
CYHS2101391Generic2021/07/05Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗

Changes in the last 90 days

10 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 3 applicationsNo longer listed under review: 4 applicationsSupplement delivery: 3 applications

  1. 2026/11/10No longer listed under review

    Polymyxin B sulfate for Injection

    CYHS2501237

    Fact date: 2026/11/10 · Date added to this site: 2026/11/10

    Accepted: 2025/04/01

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  2. 2026/11/07No longer listed under review

    Latamoxef Sodium for Injection

    CYHB2601940

    Fact date: 2026/11/07 · Date added to this site: 2026/11/07

    Accepted: 2026/10/22

    no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 47

    NMPA · Table row 47 ↗ View source ↗
  3. 2026/11/07No longer listed under review

    Latamoxef Sodium for Injection

    CYHB2601939

    Fact date: 2026/11/07 · Date added to this site: 2026/11/07

    Accepted: 2026/10/22

    no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 46

    NMPA · Table row 46 ↗ View source ↗
  4. 2026/11/07No longer listed under review

    Latamoxef Sodium for Injection

    CYHB2601938

    Fact date: 2026/11/07 · Date added to this site: 2026/11/07

    Accepted: 2026/10/22

    no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 45

    NMPA · Table row 45 ↗ View source ↗
  5. 2026/11/05Supplement delivery

    Latamoxef Sodium for Injection

    CYHB2601940

    Fact date: 2026/11/05 · Publication date: 2026/11/06 · Date added to this site: 2026/11/06

    Supplemental application; excluded from new marketing approvals.

    View source · Table row 47 ↗
  6. 2026/11/05Supplement delivery

    Latamoxef Sodium for Injection

    CYHB2601939

    Fact date: 2026/11/05 · Publication date: 2026/11/06 · Date added to this site: 2026/11/06

    Supplemental application; excluded from new marketing approvals.

    View source · Table row 46 ↗
  7. 2026/11/05Supplement delivery

    Latamoxef Sodium for Injection

    CYHB2601938

    Fact date: 2026/11/05 · Publication date: 2026/11/06 · Date added to this site: 2026/11/06

    Supplemental application; excluded from new marketing approvals.

    View source · Table row 45 ↗
  8. 2026/10/22Accepted

    Latamoxef Sodium for Injection

    CYHB2601940

    Fact date: 2026/10/22 · Date added to this site: 2026/10/23

    View source ↗
  9. 2026/10/22Accepted

    Latamoxef Sodium for Injection

    CYHB2601939

    Fact date: 2026/10/22 · Date added to this site: 2026/10/23

    View source ↗
  10. 2026/10/22Accepted

    Latamoxef Sodium for Injection

    CYHB2601938

    Fact date: 2026/10/22 · Date added to this site: 2026/10/23

    View source ↗

Under review

2 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
磷苯妥英钠注射用浓溶液 · No verified English name CYHS2600629Generic2026/03/07Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
磷苯妥英钠注射用浓溶液 · No verified English name CYHS2600628Generic2026/03/07Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

17 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Ademetionine 1,4 - Butanedisulfonate For InjectionFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202549362025/07/22Generic approved under the new chemical-drug registration classificationCDE ↗
Thioctic Acid TabletsFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202548442025/07/15Generic approved under the new chemical-drug registration classificationCDE ↗
Thioctic Acid TabletsFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202548432025/07/15Generic approved under the new chemical-drug registration classificationCDE ↗
Teicoplanin for InjectionFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202537622025/04/01Generic approved under the new chemical-drug registration classificationCDE ↗
Famotidine InjectionFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202447862024/09/03Generic approved under the new chemical-drug registration classificationCDE ↗
Voriconazole for InjectionFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202444692024/07/22Generic approved under the new chemical-drug registration classificationCDE ↗
Pentoxifylline InjectionFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202440602024/06/18Generic approved under the new chemical-drug registration classificationCDE ↗
Peramivir InjectionFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202439082024/06/04Generic approved under the new chemical-drug registration classificationCDE ↗
Ornidazole TabletsFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202438002024/05/21Generic approved under the new chemical-drug registration classificationCDE ↗
Piracetam TabletsFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202470022024/01/02Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Febuxostat TabletsFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202331882023/02/14Generic approved under the new chemical-drug registration classificationCDE ↗
Febuxostat TabletsFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202331892023/02/14Generic approved under the new chemical-drug registration classificationCDE ↗
Ornidazole InjectionFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202234042022/06/16Generic approved under the new chemical-drug registration classificationCDE ↗
Ornidazole InjectionFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202234032022/06/16Generic approved under the new chemical-drug registration classificationCDE ↗
Levofloxacin InjectionFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202232462022/04/19Generic approved under the new chemical-drug registration classificationCDE ↗
Doxofylline InjectionFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202139902021/12/31Generic approved under the new chemical-drug registration classificationCDE ↗
Esomeprazole Sodium for InjectionFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.国药准字H202137082021/09/07Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

4 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
卡巴匹林钙 · No verified English nameFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Y20190006940A—CDE ↗
洛伐他汀 · No verified English nameFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Y20190005846A2025/11/13CDE ↗
硫酸庆大霉素 · No verified English nameFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Y20190002059A2025/05/29CDE ↗
硫辛酸 · No verified English nameFuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.Y20190001222A—CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

4 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Clindamycin Injection CYHB2101956Supplement2021/10/11Guang'an Kingday Pharma & Chem Co., Ltd; Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Clindamycin Injection CYHS2101129Generic2021/05/14Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized; Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Clindamycin Injection CYHS2101128Generic2021/05/14Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized; Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗
Clindamycin Injection CYHS2101127Generic2021/05/14Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized; Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.